Identifai was established to enable comprehensive analysis of the fetal genome, providing a complete view of the fetus’s genetic health and enabling timely action for better fetal care.
From a single maternal blood draw, the company's proprietary technology sequences a mixture of fetal and maternal cell-free DNA, then uses statistical models and AI to predict fetal genetic variants at the single-letter level.